Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.262EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.262ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.262ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBUEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBUEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBUECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBUECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBUEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBUEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBUENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.351.5 (Beta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.351.5 (Beta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.351.5 (Beta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.351.5 (Beta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.351.5 (Beta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.351.5 (Beta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.351.5 (Beta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.351.5 (Beta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FZ.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FZ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FZ.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JB.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JB.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JB.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JB.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JB.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.3.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.3.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.3.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.3.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.3.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.3.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used